Healthcare provider profile · identity verified

Michael J Best, MD

Family Practice · MICHIGAN CITY, IN · NPI 1083621510

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	398	118
Levothyroxine Sodium	Levothyroxine Sodium	385	97
Rosuvastatin Calcium	Rosuvastatin Calcium	380	110
Amlodipine Besylate	Amlodipine Besylate	359	97
Omeprazole	Omeprazole	308	83
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	283	46
Metoprolol Succinate	Metoprolol Succinate	279	83
Tamsulosin Hcl	Tamsulosin Hcl	239	65
Benazepril Hcl	Benazepril Hcl	231	59
Alprazolam	Alprazolam	220	31
Spironolactone	Spironolactone	172	49
Meloxicam	Meloxicam	166	44
Pantoprazole Sodium	Pantoprazole Sodium	164	43
Losartan Potassium	Losartan Potassium	162	40
Albuterol Sulfate Hfa	Albuterol Sulfate	161	39
Metformin Hcl Er	Metformin Hcl	161	50
Lisinopril	Lisinopril	156	45
Furosemide	Furosemide	152	50
Escitalopram Oxalate	Escitalopram Oxalate	149	36
Gabapentin	Gabapentin	147	34
Clonazepam	Clonazepam	135	21
Bupropion Xl	Bupropion Hcl	134	22
Diclofenac Sodium	Diclofenac Sodium	132	39
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	131	15
Finasteride	Finasteride	121	32
Hydrochlorothiazide	Hydrochlorothiazide	120	37
Zolpidem Tartrate	Zolpidem Tartrate	120	24
Duloxetine Hcl	Duloxetine Hcl	112	25
Mounjaro	Tirzepatide	103	14
Allopurinol	Allopurinol	98	26
Pregabalin	Pregabalin	97	21
Solifenacin Succinate	Solifenacin Succinate	91	28
Prednisone	Prednisone	90	45
Carvedilol	Carvedilol	89	23
Sertraline Hcl	Sertraline Hcl	89	24
Chlorthalidone	Chlorthalidone	87	27
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	87	suppressed
Montelukast Sodium	Montelukast Sodium	86	22
Eliquis	Apixaban	80	13
Glimepiride	Glimepiride	77	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	77	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	15
Potassium Chloride	Potassium Chloride	70	22
Metformin Hcl	Metformin Hcl	69	19
Tramadol Hcl	Tramadol Hcl	66	suppressed
Trazodone Hcl	Trazodone Hcl	64	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	14
Pravastatin Sodium	Pravastatin Sodium	60	19
Citalopram Hbr	Citalopram Hydrobromide	59	17
Lamotrigine	Lamotrigine	55	12
Sumatriptan Succinate	Sumatriptan Succinate	52	suppressed
Valsartan	Valsartan	52	15
Alendronate Sodium	Alendronate Sodium	51	16
Olmesartan Medoxomil	Olmesartan Medoxomil	51	13
Azithromycin	Azithromycin	50	38
Simvastatin	Simvastatin	50	15
Donepezil Hcl	Donepezil Hcl	49	15
Clopidogrel	Clopidogrel Bisulfate	48	13
Lorazepam	Lorazepam	48	suppressed
Midodrine Hcl	Midodrine Hcl	48	11
Testosterone Cypionate	Testosterone Cypionate	48	suppressed
Topiramate	Topiramate	46	18
Xarelto	Rivaroxaban	46	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	13
Metoprolol Tartrate	Metoprolol Tartrate	43	11
Methylprednisolone	Methylprednisolone	41	37
Ondansetron Odt	Ondansetron	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Diazepam	Diazepam	35	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Temazepam	Temazepam	35	suppressed
Ketoconazole	Ketoconazole	34	24
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Tresiba Flextouch U-200	Insulin Degludec	34	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	22
Ipratropium Bromide	Ipratropium Bromide	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Klor-Con M20	Potassium Chloride	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Aripiprazole	Aripiprazole	30	suppressed
Ozempic	Semaglutide	30	suppressed
Cephalexin	Cephalexin	29	22
Prazosin Hcl	Prazosin Hcl	29	suppressed
Famotidine	Famotidine	28	suppressed
Naproxen	Naproxen	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Flecainide Acetate	Flecainide Acetate	24	suppressed
Fluconazole	Fluconazole	24	13
Levetiracetam	Levetiracetam	24	suppressed
Lidocaine	Lidocaine	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	23	16
Divalproex Sodium	Divalproex Sodium	21	suppressed
Mupirocin	Mupirocin	21	15
Nifedipine Er	Nifedipine	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Primidone	Primidone	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Bumetanide	Bumetanide	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Lurasidone Hcl	Lurasidone Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Estradiol	Estradiol	17	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Metronidazole	Metronidazole	17	16
Prasugrel Hcl	Prasugrel Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Atenolol	Atenolol	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error